Quanex Building Products Announces Third Quarter 2023 Results and Updates Full Year 2023 Guidance

In this article:
Quanex Building Products CorporationQuanex Building Products Corporation
Quanex Building Products Corporation

Record Quarter for Earnings
Margin Expansion Across All Operating Segments
Repaid $25 Million in Bank Debt
Balance Sheet and Liquidity Remain Strong
Solid Improvement in Cash Provided by Operating Activities

HOUSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended July 31, 2023.

The Company reported the following selected financial results:

 

Three Months Ended July 31,

 

Nine Months Ended July 31,

($ in millions, except per share data)

2023

 

2022

 

2023

 

2022

Net Sales

$299.6

 

$324.0

 

$835.1

 

$914.0

Gross Margin

$78.6

 

$72.6

 

$197.5

 

$201.0

Gross Margin %

26.2%

 

22.4%

 

23.7%

 

22.0%

Net Income

$31.7

 

$25.9

 

$55.1

 

$63.7

Diluted EPS

$0.96

 

$0.78

 

$1.67

 

$1.91

 

 

 

 

 

 

 

 

Adjusted Net Income

$31.9

 

$26.2

 

$59.7

 

$64.0

Adjusted Diluted EPS

$0.97

 

$0.79

 

$1.81

 

$1.92

Adjusted EBITDA

$48.5

 

$44.2

 

$108.8

 

$113.8

Adjusted EBITDA Margin %

16.2%

 

13.6%

 

13.0%

 

12.5%

 

 

 

 

 

 

 

 

Cash Provided by Operating Activities

$64.1

 

$51.7

 

$102.6

 

$49.9

Free Cash Flow

$56.7

 

$46.0

 

$80.1

 

$30.4

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, President and Chief Executive Officer, stated, “The results we reported for the three months ended July 31, 2023 were a record for Quanex from both an earnings and margin perspective. Demand continued to improve across all product lines during the third quarter of this year compared to the first half of the year. In addition, we believe the customer inventory rebalancing that impacted results in our fenestration segments in the first half have subsided and did not affect third quarter results.

“When compared to the third quarter of 2022, revenue declined in the third quarter of 2023 across all operating segments as ongoing macroeconomic challenges led to market volume declines and some pricing pressure, mostly due to surcharge rollbacks and index pricing decreases in North America as raw material costs declined. Despite this pressure on the topline, we converted well and realized margin expansion across all operating segments. Our continued focus on operational efficiency proved beneficial and our ability to flex our cost structure to meet demand trends across product lines also helped improve our profitability during the quarter.

“We continue to do a good job of managing working capital and generating cash, which enabled us to pay down our bank debt by $25 million during the third quarter. In fact, we are currently on track to generate record free cash flow this year. In addition, our balance sheet remains strong, and our leverage ratio improved compared to the second quarter of this year.” (See Non-GAAP Terminology Definitions and Disclaimers section for additional information)

Third Quarter 2023 Results Summary

The Company reported net sales of $299.6 million during the three months ended July 31, 2023, which represents a decrease of 7.5% compared to $324.0 million for the same period of 2022. The decrease was mostly attributable to softer market demand and lower pricing in North America.   Quanex realized a decline in net sales of 4.1% for the third quarter of 2023 in its North American Fenestration segment. Excluding the contribution from the LMI Custom Mixing assets we acquired on November 1, 2022, net sales in the North American Fenestration segment would have declined by 14.9% year-over-year. The Company reported a decline in net sales of 23.6% in its North American Cabinet Components segment and a decrease of 2.8% in net sales in its European Fenestration segment, excluding foreign exchange impact. (See Sales Analysis table for additional information)

The increase in earnings for the three months ended July 31, 2023 was largely attributable to operational efficiency gains, cost control and a decrease in income tax expense. As such, Quanex was able to realize margin expansion in each of its operating segments and on a consolidated basis.

Balance Sheet Update

As of July 31, 2023, Quanex had total debt of $110.8 million ($57.9 million excluding real-estate leases that are considered “finance” leases under U.S. GAAP) and the Company’s leverage ratio of Net Debt to LTM Adjusted EBITDA decreased to 0.3x (Net Debt free excluding these real-estate leases). As of July 31, 2023, Quanex’s LTM Adjusted EBITDA was $147.5 million and LTM Net Income, the most directly comparable GAAP measure, was $79.8 million.   (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

Outlook

Mr. Wilson commented, “We were cautiously optimistic heading into the second half of our fiscal year based on our belief that we were seeing a return to normal seasonality. Our third quarter results reinforced that belief. Based on our results year-to-date, combined with our operational execution, recent demand trends and conversations with our customers, we are updating our guidance for fiscal 2023. On a consolidated basis for fiscal 2023, we currently estimate that we will generate net sales of approximately $1.125 billion, which is towards the lower end of prior guidance as indicated on our last earnings call; however, we are increasing our Adjusted EBITDA* guidance to $150 million to $155 million.

Our capital allocation priorities continue to be generating cash, paying down debt, evaluating growth opportunities and opportunistically buying back our stock.”

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes.

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, September 1, 2023 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register.vevent.com/register/BI9e428e0cc86a46139a82d87ee6276d56

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, vinyl fencing, solar, refrigeration and cabinetry markets.  Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

For more information contact Scott Zuehlke, Senior Vice President, Chief Financial Officer & Treasurer, at 713-877-5327 or scott.zuehlke@quanex.com.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges, asset impairment charges, other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net) and Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making.  Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement. Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making.   Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance. Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities.  The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics, such as the recent COVID-19 pandemic) on the economy and the demand for Quanex’s products, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2022, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended July 31,

 

Nine Months Ended July 31,

 

 

2023

 

2022

 

2023

 

2022

 

 

 

 

 

 

 

 

 

Net sales

 

$

299,640

 

 

$

324,037

 

 

$

835,091

 

 

$

913,970

 

Cost of sales

 

 

221,065

 

 

 

251,446

 

 

 

637,586

 

 

 

712,931

 

Selling, general and administrative

 

 

30,516

 

 

 

28,822

 

 

 

94,631

 

 

 

87,774

 

Depreciation and amortization

 

 

10,596

 

 

 

9,734

 

 

 

31,672

 

 

 

30,554

 

Operating income

 

 

37,463

 

 

 

34,035

 

 

 

71,202

 

 

 

82,711

 

Interest expense

 

 

(2,068

)

 

 

(724

)

 

 

(6,571

)

 

 

(1,849

)

Other, net

 

 

402

 

 

 

398

 

 

 

591

 

 

 

905

 

Income before income taxes

 

 

35,797

 

 

 

33,709

 

 

 

65,222

 

 

 

81,767

 

Income tax expense

 

 

(4,099

)

 

 

(7,801

)

 

 

(10,103

)

 

 

(18,098

)

Net income

 

$

31,698

 

 

$

25,908

 

 

$

55,119

 

 

$

63,669

 

 

 

 

 

 

 

 

 

 

Earnings per common share, basic

 

$

0.97

 

 

$

0.79

 

 

$

1.68

 

 

$

1.92

 

Earnings per common share, diluted

 

$

0.96

 

 

$

0.78

 

 

$

1.67

 

 

$

1.91

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

32,716

 

 

 

32,999

 

 

 

32,841

 

 

 

33,093

 

Diluted

 

 

32,919

 

 

 

33,173

 

 

 

33,031

 

 

 

33,256

 

 

 

 

 

 

 

 

 

 

Cash dividends per share

 

$

0.08

 

 

$

0.08

 

 

$

0.24

 

 

$

0.24

 

 

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

July 31, 2023

 

October 31, 2022

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

73,252

 

 

$

55,093

 

Accounts receivable, net

 

 

96,204

 

 

 

96,018

 

Inventories, net

 

 

105,368

 

 

 

120,890

 

Prepaid and other current assets

 

 

12,764

 

 

 

8,664

 

Total current assets

 

 

287,588

 

 

 

280,665

 

Property, plant and equipment, net

 

 

245,912

 

 

 

180,400

 

Operating lease right-of-use assets

 

 

45,804

 

 

 

56,000

 

Goodwill

 

 

186,409

 

 

 

137,855

 

Intangible assets, net

 

 

78,617

 

 

 

65,035

 

Other assets

 

 

3,479

 

 

 

4,662

 

Total assets

 

$

847,809

 

 

$

724,617

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

71,464

 

 

$

77,907

 

Accrued liabilities

 

 

54,237

 

 

 

52,114

 

Income taxes payable

 

 

-

 

 

 

1,049

 

Current maturities of long-term debt

 

 

2,278

 

 

 

1,046

 

Current operating lease liabilities

 

 

7,388

 

 

 

7,727

 

Total current liabilities

 

 

135,367

 

 

 

139,843

 

Long-term debt

 

 

107,234

 

 

 

29,628

 

Noncurrent operating lease liabilities

 

 

39,291

 

 

 

49,286

 

Deferred pension benefits

 

 

-

 

 

 

3,917

 

Deferred income taxes

 

 

23,741

 

 

 

22,277

 

Other liabilities

 

 

16,221

 

 

 

14,831

 

Total liabilities

 

 

321,854

 

 

 

259,782

 

Stockholders’ equity:

 

 

 

 

Common stock

 

 

372

 

 

 

372

 

Additional paid-in-capital

 

 

250,882

 

 

 

251,947

 

Retained earnings

 

 

384,623

 

 

 

337,456

 

Accumulated other comprehensive loss

 

 

(31,890

)

 

 

(49,422

)

Treasury stock at cost

 

 

(78,032

)

 

 

(75,518

)

Total stockholders’ equity

 

 

525,955

 

 

 

464,835

 

Total liabilities and stockholders' equity

 

$

847,809

 

 

$

724,617

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)

 

 

 

 

 

Nine Months Ended July 31,

 

2023

 

2022

Operating activities:

 

 

 

Net income

$

55,119

 

 

$

63,669

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

Depreciation and amortization

 

31,672

 

 

 

30,554

 

Loss on the disposition of capital assets

 

 

 

Stock-based compensation

 

1,828

 

 

 

1,707

 

Deferred income tax

 

177

 

 

 

505

 

Other, net

 

2,423

 

 

 

2,647

 

Changes in assets and liabilities:

 

 

 

Decrease (increase) in accounts receivable

 

9,918

 

 

 

(5,306

)

Decrease (increase) in inventory

 

23,864

 

 

 

(48,280

)

Increase in other current assets

 

(439

)

 

 

(824

)

(Decrease) increase in accounts payable

 

(15,471

)

 

 

2,765

 

Decrease in accrued liabilities

 

(5,152

)

 

 

(4,721

)

(Decrease) increase in income taxes payable

 

(3,534

)

 

 

7,522

 

Increase (decrease) in deferred pension benefits

 

22

 

 

 

(239

)

Increase in other long-term liabilities

 

609

 

 

 

32

 

Other, net

 

1,523

 

 

 

(177

)

Cash provided by operating activities

 

102,559

 

 

 

49,854

 

Investing activities:

 

 

 

Business acquisition

 

(91,302

)

 

 

-

 

Capital expenditures

 

(22,450

)

 

 

(19,488

)

Proceeds from disposition of capital assets

 

183

 

 

 

134

 

Cash used for investing activities

 

(113,569

)

 

 

(19,354

)

Financing activities:

 

 

 

Borrowings under credit facilities

 

102,000

 

 

 

70,500

 

Repayments of credit facility borrowings

 

(60,000

)

 

 

(70,500

)

Debt issuance costs

 

-

 

 

 

(1,210

)

Repayments of other long-term debt

 

(1,954

)

 

 

(1,301

)

Common stock dividends paid

 

(7,952

)

 

 

(7,916

)

Issuance of common stock

 

753

 

 

 

502

 

Payroll tax paid to settle shares forfeited upon vesting of stock

 

(567

)

 

 

(1,412

)

Purchase of treasury stock

 

(5,593

)

 

 

(6,600

)

Cash provided by (used for) financing activities

 

26,687

 

 

 

(17,937

)

Effect of exchange rate changes on cash and cash equivalents

 

2,482

 

 

 

(2,594

)

Decrease in cash and cash equivalents

 

18,159

 

 

 

9,969

 

Cash and cash equivalents at beginning of period

 

55,093

 

 

 

40,061

 

Cash and cash equivalents at end of period

$

73,252

 

 

$

50,030

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.

 

 

 

 

 

 

 

 

 

Three Months Ended July 31,

 

Nine Months Ended July 31,

 

2023

 

2022

 

2023

 

2022

Cash provided by operating activities

$64,099

 

$51,735

 

$102,559

 

$49,854

Capital expenditures

(7,376)

 

(5,703)

 

(22,450)

 

(19,488)

Free Cash Flow

$56,723

 

$46,032

 

$80,109

 

$30,366

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.

 

 

 

 

 

 

 

 

 

As of July 31,

 

 

 

2023

 

2022

 

 

 

 

Revolving credit facility

$55,000

 

$38,000

 

 

 

 

Finance lease obligations(1)

55,792

 

20,105

 

 

 

 

Total debt(2)

110,792

 

58,105

 

 

 

 

Less: Cash and cash equivalents

73,252

 

50,030

 

 

 

 

Net Debt

$37,540

 

$8,075

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes $52.9 million and $18.8 million in real estate lease liabilities considered finance leases under U.S. GAAP as of July 31, 2023 and July 31, 2022, respectively.

(2) Excludes outstanding letters of credit.

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Last Twelve Months Adjusted EBITDA

 

Three Months Ended July 31, 2023

 

Three Months Ended April 30, 2023

 

Three Months Ended January 31, 2023

 

Three Months Ended October 31, 2022

 

Total

 

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

Net income as reported

 

$

31,698

 

 

$

21,512

 

$

1,909

 

 

$

24,667

 

 

$

79,786

 

Income tax expense

 

 

4,099

 

 

 

5,551

 

 

453

 

 

 

3,329

 

 

 

13,432

 

Other, net

 

 

(402

)

 

 

29

 

 

(218

)

 

 

(136

)

 

 

(727

)

Interest expense

 

 

2,068

 

 

 

2,244

 

 

2,259

 

 

 

710

 

 

 

7,281

 

Depreciation and amortization

 

 

10,596

 

 

 

10,456

 

 

10,620

 

 

 

9,555

 

 

 

41,227

 

EBITDA

 

 

48,059

 

 

 

39,792

 

 

15,023

 

 

 

38,125

 

 

 

140,999

 

Cost of sales(1)

 

 

-

 

 

 

48

 

 

-

 

 

 

-

 

 

 

48

 

Selling, general and administrative(1),(2)

 

 

395

 

 

 

63

 

 

5,448

 

 

 

564

 

 

 

6,470

 

Adjusted EBITDA

 

$

48,454

 

 

$

39,903

 

$

20,471

 

 

$

38,689

 

 

$

147,517

 

 

 

 

 

 

 

 

 

 

 

 

(1) Loss on damage to manufacturing facilities caused by weather.

(2) Transaction and advisory fees.

 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted Net Income and Adjusted EPS

 

Three Months Ended
July 31, 2023

 

Three Months Ended
July 31, 2022

 

Nine Months Ended
July 31, 2023

 

Nine Months Ended
July 31, 2022

 

 

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net income as reported

 

$

31,698

 

 

$

0.96

 

 

$

25,908

 

 

$

0.78

 

 

$

55,119

 

 

$

1.67

 

 

$

63,669

 

 

$

1.91

 

 

Net income reconciling items from below

 

201

 

 

$

0.01

 

 

257

 

 

$

0.01

 

 

4,550

 

 

$

0.14

 

 

291

 

 

$

0.01

 

 

Adjusted net income and adjusted EPS

 

$

31,899

 

 

$

0.97

 

 

$

26,165

 

 

$

0.79

 

 

$

59,669

 

 

$

1.81

 

 

$

63,960

 

 

$

1.92

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted EBITDA

 

Three Months Ended
July 31, 2023

 

Three Months Ended
July 31, 2022

 

Nine Months Ended
July 31, 2023

 

Nine Months Ended
July 31, 2022

 

 

 

Reconciliation

 

 

 

 

Reconciliation

 

 

 

 

Reconciliation

 

 

 

 

Reconciliation

 

 

 

 

Net income as reported

 

$

31,698

 

 

 

 

 

$

25,908

 

 

 

 

 

$

55,119

 

 

 

 

 

$

63,669

 

 

 

 

 

Income tax expense

 

4,099

 

 

 

 

 

7,801

 

 

 

 

 

10,103

 

 

 

 

 

18,098

 

 

 

 

 

Other, net

 

(402

)

 

 

 

 

(398

)

 

 

 

 

(591

)

 

 

 

 

(905

)

 

 

 

 

Interest expense

 

2,068

 

 

 

 

 

724

 

 

 

 

 

6,571

 

 

 

 

 

1,849

 

 

 

 

 

Depreciation and amortization

 

10,596

 

 

 

 

 

9,734

 

 

 

 

 

31,672

 

 

 

 

 

30,554

 

 

 

 

 

EBITDA

 

48,059

 

 

 

 

 

43,769

 

 

 

 

 

102,874

 

 

 

 

 

113,265

 

 

 

 

 

EBITDA reconciling items from below

 

395

 

 

 

 

 

419

 

 

 

 

 

5,954

 

 

 

 

 

550

 

 

 

 

 

Adjusted EBITDA

 

$

48,454

 

 

 

 

 

$

44,188

 

 

 

 

 

$

108,828

 

 

 

 

 

$

113,815

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciling Items

 

Three Months Ended
July 31, 2023

 

Three Months Ended
July 31, 2022

 

Nine Months Ended
July 31, 2023

 

Nine Months Ended
July 31, 2022

 

 

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Net sales

 

$

299,640

 

 

$

-

 

 

$

324,037

 

 

$

-

 

 

$

835,091

 

 

$

-

 

 

$

913,970

 

 

$

-

 

 

Cost of sales

 

221,065

 

 

-

 

 

251,446

 

 

-

 

 

637,586

 

 

(48

)

(1)

712,931

 

 

-

 

 

Selling, general and administrative

 

30,516

 

 

(395

)

(2)

28,822

 

 

(419

)

(2)

94,631

 

 

(5,906

)

(1),(2)

87,774

 

 

(550

)

(2)

EBITDA

 

48,059

 

 

395

 

 

43,769

 

 

419

 

 

102,874

 

 

5,954

 

 

113,265

 

 

550

 

 

Depreciation and amortization

 

10,596

 

 

-

 

 

9,734

 

 

-

 

 

31,672

 

 

-

 

 

30,554

 

 

-

 

 

Operating income

 

37,463

 

 

395

 

 

34,035

 

 

419

 

 

71,202

 

 

5,954

 

 

82,711

 

 

550

 

 

Interest expense

 

(2,068

)

 

-

 

 

(724

)

 

-

 

 

(6,571

)

 

-

 

 

(1,849

)

 

-

 

 

Other, net

 

402

 

 

(126

)

(3)

398

 

 

(82

)

(3)

591

 

 

(36

)

(3)

905

 

 

(164

)

(3)

Income before income taxes

 

35,797

 

 

269

 

 

33,709

 

 

337

 

 

65,222

 

 

5,918

 

 

81,767

 

 

386

 

 

Income tax expense

 

(4,099

)

 

(68

)

(4)

(7,801

)

 

(80

)

(4)

(10,103

)

 

(1,368

)

(4)

(18,098

)

 

(95

)

(4)

Net income

 

$

31,698

 

 

$

201

 

 

$

25,908

 

 

$

257

 

 

$

55,119

 

 

$

4,550

 

 

$

63,669

 

 

$

291

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

$

0.96

 

 

 

 

 

$

0.78

 

 

 

 

 

$

1.67

 

 

 

 

 

$

1.91

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Loss on damage to manufacturing facilities caused by weather.

(2) Transaction and advisory fees.

(3) Foreign currency transaction gains.

(4)Tax impact of net income reconciling items.

 


 

QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.

 

 

NA Fenestration

 

EU Fenestration

 

NA Cabinet Components

 

Unallocated Corp & Other

 

Total

Three months ended July 31, 2023

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

177,081

 

 

$

67,889

 

 

$

55,385

 

 

$

(715

)

 

$

299,640

 

Cost of sales

 

 

135,126

 

 

 

41,266

 

 

 

44,935

 

 

 

(262

)

 

 

221,065

 

Gross Margin

 

 

41,955

 

 

 

26,623

 

 

 

10,450

 

 

 

(453

)

 

 

78,575

 

Gross Margin %

 

 

23.7

%

 

 

39.2

%

 

 

18.9

%

 

 

 

 

26.2

%

Selling, general and administrative

 

 

14,254

 

 

 

8,039

 

 

 

5,095

 

 

 

3,128

 

 

 

30,516

 

Depreciation and amortization

 

 

5,033

 

 

 

2,434

 

 

 

3,084

 

 

 

45

 

 

 

10,596

 

Operating income (loss)

 

 

22,668

 

 

 

16,150

 

 

 

2,271

 

 

 

(3,626

)

 

 

37,463

 

Depreciation and amortization

 

 

5,033

 

 

 

2,434

 

 

 

3,084

 

 

 

45

 

 

 

10,596

 

EBITDA

 

 

27,701

 

 

 

18,584

 

 

 

5,355

 

 

 

(3,581

)

 

 

48,059

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

395

 

 

 

395

 

Adjusted EBITDA

 

$

27,701

 

 

$

18,584

 

 

$

5,355

 

 

$

(3,186

)

 

$

48,454

 

Adjusted EBITDA Margin %

 

 

15.6

%

 

 

27.4

%

 

 

9.7

%

 

 

 

 

16.2

%

 

 

 

 

 

 

 

 

 

 

 

Three months ended July 31, 2022

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

184,744

 

 

$

67,613

 

 

$

72,480

 

 

$

(800

)

 

$

324,037

 

Cost of sales

 

 

142,970

 

 

 

47,212

 

 

 

61,543

 

 

 

(279

)

 

 

251,446

 

Gross Margin

 

 

41,774

 

 

 

20,401

 

 

 

10,937

 

 

 

(521

)

 

 

72,591

 

Gross Margin %

 

 

22.6

%

 

 

30.2

%

 

 

15.1

%

 

 

 

 

22.4

%

Selling, general and administrative

 

 

14,644

 

 

 

8,256

 

 

 

5,335

 

 

 

587

 

 

 

28,822

 

Depreciation and amortization

 

 

4,044

 

 

 

2,327

 

 

 

3,273

 

 

 

90

 

 

 

9,734

 

Operating income (loss)

 

 

23,086

 

 

 

9,818

 

 

 

2,329

 

 

 

(1,198

)

 

 

34,035

 

Depreciation and amortization

 

 

4,044

 

 

 

2,327

 

 

 

3,273

 

 

 

90

 

 

 

9,734

 

EBITDA

 

 

27,130

 

 

 

12,145

 

 

 

5,602

 

 

 

(1,108

)

 

 

43,769

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

419

 

 

 

419

 

Adjusted EBITDA

 

$

27,130

 

 

$

12,145

 

 

$

5,602

 

 

$

(689

)

 

$

44,188

 

Adjusted EBITDA Margin %

 

 

14.7

%

 

 

18.0

%

 

 

7.7

%

 

 

 

 

13.6

%

 

 

 

 

 

 

 

 

 

 

 

Nine months ended July 31, 2023

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

487,036

 

 

$

186,604

 

 

$

163,577

 

 

$

(2,126

)

 

$

835,091

 

Cost of sales

 

 

382,315

 

 

 

119,421

 

 

 

136,722

 

 

 

(872

)

 

 

637,586

 

Gross Margin

 

 

104,721

 

 

 

67,183

 

 

 

26,855

 

 

 

(1,254

)

 

 

197,505

 

Gross Margin %

 

 

21.5

%

 

 

36.0

%

 

 

16.4

%

 

 

 

 

23.7

%

Selling, general and administrative

 

 

41,707

 

 

 

23,996

 

 

 

15,939

 

 

 

12,989

 

 

 

94,631

 

Depreciation and amortization

 

 

15,328

 

 

 

7,135

 

 

 

8,988

 

 

 

221

 

 

 

31,672

 

Operating income (loss)

 

 

47,686

 

 

 

36,052

 

 

 

1,928

 

 

 

(14,464

)

 

 

71,202

 

Depreciation and amortization

 

 

15,328

 

 

 

7,135

 

 

 

8,988

 

 

 

221

 

 

 

31,672

 

EBITDA

 

 

63,014

 

 

 

43,187

 

 

 

10,916

 

 

 

(14,243

)

 

 

102,874

 

Loss on damage to manufacturing facilities (Cost of sales)

 

 

35

 

 

 

-

 

 

 

13

 

 

 

-

 

 

 

48

 

Loss on damage to manufacturing facilities (SG&A)

 

 

-

 

 

 

-

 

 

 

200

 

 

 

-

 

 

 

200

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,706

 

 

 

5,706

 

Adjusted EBITDA

 

$

63,049

 

 

$

43,187

 

 

$

11,129

 

 

$

(8,537

)

 

$

108,828

 

Adjusted EBITDA Margin %

 

 

12.9

%

 

 

23.1

%

 

 

6.8

%

 

 

 

 

13.0

%

 

 

 

 

 

 

 

 

 

 

 

Nine months ended July 31, 2022

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

509,283

 

 

$

199,954

 

 

$

207,711

 

 

$

(2,978

)

 

$

913,970

 

Cost of sales

 

 

396,505

 

 

 

138,147

 

 

 

179,791

 

 

 

(1,512

)

 

 

712,931

 

Gross Margin

 

 

112,778

 

 

 

61,807

 

 

 

27,920

 

 

 

(1,466

)

 

 

201,039

 

Gross Margin %

 

 

22.1

%

 

 

30.9

%

 

 

13.4

%

 

 

 

 

22.0

%

Selling, general and administrative

 

 

43,099

 

 

 

24,160

 

 

 

15,823

 

 

 

4,692

 

 

 

87,774

 

Depreciation and amortization

 

 

12,221

 

 

 

7,418

 

 

 

10,653

 

 

 

262

 

 

 

30,554

 

Operating income (loss)

 

 

57,458

 

 

 

30,229

 

 

 

1,444

 

 

 

(6,420

)

 

 

82,711

 

Depreciation and amortization

 

 

12,221

 

 

 

7,418

 

 

 

10,653

 

 

 

262

 

 

 

30,554

 

EBITDA

 

 

69,679

 

 

 

37,647

 

 

 

12,097

 

 

 

(6,158

)

 

 

113,265

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

550

 

 

 

550

 

Adjusted EBITDA

 

$

69,679

 

 

$

37,647

 

 

$

12,097

 

 

$

(5,608

)

 

$

113,815

 

Adjusted EBITDA Margin %

 

 

13.7

%

 

 

18.8

%

 

 

5.8

%

 

 

 

 

12.5

%

 

 

 

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended July 31,

 

Nine Months Ended July 31,

 

 

2023

 

2022

 

2023

 

2022

 

 

 

 

 

 

 

 

 

NA Fenestration:(1)

 

 

 

 

 

 

 

 

United States - fenestration

$

138,090

 

 

$

162,215

 

 

$

379,613

 

 

$

447,425

 

 

International - fenestration

 

8,542

 

 

 

10,722

 

 

 

22,019

 

 

 

30,952

 

 

United States - non-fenestration

 

26,423

 

 

 

8,324

 

 

 

73,823

 

 

 

22,117

 

 

International - non-fenestration

 

4,026

 

 

 

3,483

 

 

 

11,581

 

 

 

8,789

 

 

 

$

177,081

 

 

$

184,744

 

 

$

487,036

 

 

$

509,283

 

EU Fenestration:(2)

 

 

 

 

 

 

 

 

International - fenestration

$

51,752

 

 

$

49,041

 

 

$

142,009

 

 

$

148,525

 

 

International - non-fenestration

 

16,137

 

 

 

18,572

 

 

 

44,595

 

 

 

51,429

 

 

 

$

67,889

 

 

$

67,613

 

 

$

186,604

 

 

$

199,954

 

NA Cabinet Components:

 

 

 

 

 

 

 

 

United States - fenestration

$

4,486

 

 

$

4,857

 

 

$

12,613

 

 

$

13,288

 

 

United States - non-fenestration

 

50,199

 

 

 

66,758

 

 

 

148,774

 

 

 

191,908

 

 

International - non-fenestration

 

700

 

 

 

865

 

 

 

2,190

 

 

 

2,515

 

 

 

$

55,385

 

 

$

72,480

 

 

$

163,577

 

 

$

207,711

 

Unallocated Corporate & Other:

 

 

 

 

 

 

 

 

Eliminations

$

(715

)

 

$

(800

)

 

$

(2,126

)

 

$

(2,978

)

 

 

$

(715

)

 

$

(800

)

 

$

(2,126

)

 

$

(2,978

)

 

 

 

 

 

 

 

 

 

Net Sales

$

299,640

 

 

$

324,037

 

 

$

835,091

 

 

$

913,970

 

 

 

 

 

 

 

 

 

 

(1) Includes the net sales from the acquisition of LMI of $19.8 million and $54.0 million for the three and nine months ended July 31, 2023, respectively.

(2) Reflects an increase of $2.2 million and a reduction of $8.6 million in revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2023, respectively.

 

 

 

 

 

 

 

 

 


Advertisement